Thomas Jefferson University is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Thomas Jefferson University has participated in 796 clinical trials with 185 currently active.
Therapeutic areas: Compensated Cirrhosis, Nonalcoholic Steatohepatitis, Pulmonary Arterial Hypertension.
Sponsors: Intercept Pharmaceuticals, Lung Biotechnology PBC, University of Michigan Rogel Cancer Center.
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Thomas Jefferson University has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Thomas Jefferson University has 796 clinical trials on record, with 185 currently active. Their work covers Compensated Cirrhosis, Nonalcoholic Steatohepatitis, Pulmonary Arterial Hypertension.
Thomas Jefferson University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.